awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35885190-F1C6FDB7-FCEE-4CB9-8196-12C395F4D505
Q35885190-F1C6FDB7-FCEE-4CB9-8196-12C395F4D505
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35885190-F1C6FDB7-FCEE-4CB9-8196-12C395F4D505
Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial
P2860
Q35885190-F1C6FDB7-FCEE-4CB9-8196-12C395F4D505
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35885190-F1C6FDB7-FCEE-4CB9-8196-12C395F4D505
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9e6a410a2864c95520c83c3a8abee41edefcd18e
P2860
HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure